Advanced Colorectal Cancer Drug Extends Survival, Maker Says
(MedPage Today) — Regorafenib, a novel treatment for metastatic colorectal cancer, extended survival in patients who had failed standard treatment compared with placebo, according to maker Bayer HealthCare Pharmaceuticals.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com